JP2919890B2
(ja)
*
|
1988-11-11 |
1999-07-19 |
メディカル リサーチ カウンスル |
単一ドメインリガンド、そのリガンドからなる受容体、その製造方法、ならびにそのリガンドおよび受容体の使用
|
JP3683282B2
(ja)
*
|
1996-10-17 |
2005-08-17 |
三菱化学株式会社 |
遺伝子型と表現型の対応付け分子及びその利用
|
US6261804B1
(en)
*
|
1997-01-21 |
2001-07-17 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
US8207093B2
(en)
|
1997-01-21 |
2012-06-26 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
CA2792122C
(en)
|
1997-07-07 |
2015-09-08 |
Medical Research Council |
In vitro sorting method
|
US20060057573A1
(en)
*
|
2002-02-15 |
2006-03-16 |
Somalogic, Inc |
Methods and reagents for detecting target binding by nucleic acid ligands
|
US6242246B1
(en)
*
|
1997-12-15 |
2001-06-05 |
Somalogic, Inc. |
Nucleic acid ligand diagnostic Biochip
|
US20070166741A1
(en)
|
1998-12-14 |
2007-07-19 |
Somalogic, Incorporated |
Multiplexed analyses of test samples
|
IL138668A0
(en)
*
|
1998-04-03 |
2001-10-31 |
Phylos Inc |
Addressable protein arrays
|
US6440695B1
(en)
|
1998-04-17 |
2002-08-27 |
Whitehead Institute For Biomedical Research |
Method for producing diverse libraries of encoded polypeptides
|
US20030170820A1
(en)
*
|
1998-05-08 |
2003-09-11 |
Gregory Coia |
Continuous in- vitro evolution
|
JP4240574B2
(ja)
*
|
1998-05-15 |
2009-03-18 |
三菱化学株式会社 |
タンパク質のラベル化組成物およびタンパク質のラベル化方法
|
US6287765B1
(en)
*
|
1998-05-20 |
2001-09-11 |
Molecular Machines, Inc. |
Methods for detecting and identifying single molecules
|
AU2004200998B2
(en)
*
|
1998-08-17 |
2007-01-11 |
Compound Therapeutics, Inc. |
Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular RNA-protein fusion formation
|
US6602685B1
(en)
*
|
1998-08-17 |
2003-08-05 |
Phylos, Inc. |
Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules
|
EP1105516A4
(de)
*
|
1998-08-17 |
2002-01-09 |
Phylos Inc |
Verfahren zur herstellung von nukleinsäuren mit fehlenden 3'-untranslatierten regionen und optimierung des formens zellulärer rna-protein fusiosen
|
PT1137812E
(pt)
*
|
1998-12-02 |
2007-05-31 |
Adnexus Therapeutics Inc |
Fusões adn-proteína e suas utilizações
|
US7115396B2
(en)
|
1998-12-10 |
2006-10-03 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
US6818418B1
(en)
*
|
1998-12-10 |
2004-11-16 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
WO2000034784A1
(en)
*
|
1998-12-10 |
2000-06-15 |
Phylos, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
GB9900298D0
(en)
*
|
1999-01-07 |
1999-02-24 |
Medical Res Council |
Optical sorting method
|
AU2004242526B2
(en)
*
|
1999-01-07 |
2007-08-30 |
United Kingdom Research And Innovation |
Optical Sorting Method
|
AU4231000A
(en)
|
1999-04-12 |
2000-11-14 |
Johns Hopkins University School Of Medicine, The |
In vitro ribosome evolution
|
DE19923966C2
(de)
*
|
1999-05-25 |
2003-04-24 |
Phylos Inc |
Erkennungssystem zur Auftrennung von Probenbestandteilen, seine Herstellung und Verwendung
|
US6623926B1
(en)
|
1999-06-01 |
2003-09-23 |
Phylos, Inc. |
Methods for producing 5′-nucleic acid-protein conjugates
|
EP1194594A4
(de)
*
|
1999-07-12 |
2005-06-01 |
Compound Therapeutics Inc |
Markierung von proteinen am c-terminus
|
AU2008200974B2
(en)
*
|
1999-07-27 |
2012-05-03 |
Bristol-Myers Squibb Company |
Peptide acceptor ligation methods
|
IL147037A0
(en)
*
|
1999-07-27 |
2002-08-14 |
Phylos Inc |
Peptide acceptor ligation methods
|
CA2382545C
(en)
*
|
1999-08-27 |
2013-08-13 |
Phylos, Inc. |
Methods for encoding and sorting in vitro translated proteins
|
AU7721100A
(en)
*
|
1999-10-01 |
2001-05-10 |
Zhongping Yu |
Compositions and methods for identifying polypeptides and nucleic acid molecules
|
DE19959857C1
(de)
*
|
1999-12-10 |
2001-06-28 |
Aventis Res & Tech Gmbh & Co |
Testsystem zum Nachweis von Analyten sowie ein Verfahren zur Herstellung und Verwendung
|
AU2788101A
(en)
*
|
2000-01-11 |
2001-07-24 |
Maxygen, Inc. |
Integrated systems and methods for diversity generation and screening
|
US7022479B2
(en)
*
|
2000-01-24 |
2006-04-04 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
JP2003520050A
(ja)
*
|
2000-01-24 |
2003-07-02 |
フィロス インク. |
タンパク質分析のための高感度多重化診断アッセイ法
|
US20010024789A1
(en)
*
|
2000-02-24 |
2001-09-27 |
Markus Kurz |
Methods for generating catalytic proteins
|
US6489106B1
(en)
*
|
2000-03-10 |
2002-12-03 |
Nec Research Institute, Inc. |
Control of the expression of anchored genes using micron scale heaters
|
US8288322B2
(en)
|
2000-04-17 |
2012-10-16 |
Dyax Corp. |
Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
|
WO2001083507A1
(en)
*
|
2000-05-05 |
2001-11-08 |
Selegen |
Identification of polypeptides and nucleic acid molecules using linkage between dna and polypeptide
|
US6962781B1
(en)
|
2000-05-19 |
2005-11-08 |
Proteonova, Inc. |
In vitro evolution of nucleic acids and encoded polypeptide
|
AU2001261771B2
(en)
*
|
2000-05-19 |
2005-06-09 |
Richard B. Williams |
In vitro evolution of nucleic acids and encoded polypeptide
|
US7410761B2
(en)
|
2000-05-19 |
2008-08-12 |
Proteonova, Inc. |
System for rapid identification and selection of nucleic acids and polypeptides, and method thereof
|
US20040229271A1
(en)
|
2000-05-19 |
2004-11-18 |
Williams Richard B. |
Compositions and methods for the identification and selection of nucleic acids and polypeptides
|
SK1152003A3
(en)
|
2000-06-29 |
2003-07-01 |
Abbott Lab |
Dual specificity antibodies and methods of making and using
|
DE10033194C2
(de)
*
|
2000-07-07 |
2002-07-18 |
Aventis Res & Tech Gmbh & Co |
Biosonden und deren Verwendung
|
AU7861301A
(en)
*
|
2000-08-15 |
2002-02-25 |
Discerna Ltd |
Functional protein arrays
|
DE10041238A1
(de)
*
|
2000-08-22 |
2002-03-07 |
Aventis Res & Tech Gmbh & Co |
Verfahren zur Identifizierung spezifisch spaltbarer peptide und Verwendung solcher Peptidsequenzen
|
IL154596A0
(en)
|
2000-08-25 |
2003-09-17 |
Basf Plant Science Gmbh |
Plant polynucleotides encoding novel prenyl proteases
|
EP1356075A4
(de)
|
2000-10-16 |
2005-04-13 |
Compound Therapeutics Inc |
Proteingerüste für antikörpermimetika und andere bindungsproteine
|
US6841359B2
(en)
|
2000-10-31 |
2005-01-11 |
The General Hospital Corporation |
Streptavidin-binding peptides and uses thereof
|
EP2360275B1
(de)
*
|
2000-11-15 |
2018-03-28 |
Minerva Biotechnologies Corporation |
Oligonukleotididentifikatoren
|
EP1350846A4
(de)
*
|
2000-12-07 |
2005-01-26 |
Univ Keio |
C-terminales modifiziertes protein und verfahren zu seiner herstellung, bei der herstellung von c-terminalem modifiziertem protein zu verwendendes modifikationsmittel und translationsvorlage und verfahren zum nachweis von proteinwechselwirkung unter verwendung des c-terminalen modifizierten proteins
|
JP4963142B2
(ja)
*
|
2000-12-14 |
2012-06-27 |
学校法人慶應義塾 |
遺伝子型と表現型の対応付け分子とその構成要素、および対応付け分子の製造方法と利用方法
|
DK1353941T3
(da)
*
|
2001-01-22 |
2013-06-17 |
Sangamo Biosciences Inc |
Modificerede zinkfingerbindingsproteiner
|
JP4880188B2
(ja)
|
2001-01-23 |
2012-02-22 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
核酸プログラム型タンパク質アレイ
|
CA2441820C
(en)
*
|
2001-03-19 |
2014-01-07 |
President And Fellows Of Harvard College |
Evolving new molecular function
|
US20040253578A1
(en)
*
|
2001-04-02 |
2004-12-16 |
Roberts Radclyffe L. |
Dynamic action reference tools
|
AU2002256076A1
(en)
*
|
2001-04-10 |
2002-10-28 |
Interlock Industries, Inc. |
Water based adhesive
|
JP2008099700A
(ja)
*
|
2001-05-11 |
2008-05-01 |
National Institute Of Advanced Industrial & Technology |
任意のポリペプチドをコードするDNAの転写産物と翻訳産物との安定的な複合体を形成させる方法、該方法に用いる核酸構築物、該方法により形成される複合体、並びに該方法を利用した機能性タンパク質および該タンパク質をコードするmRNAまたはDNAのスクリーニング
|
US20060234231A1
(en)
*
|
2001-06-20 |
2006-10-19 |
Nuevolution A/S |
Microarrays displaying encoded molecules
|
NZ530098A
(en)
*
|
2001-06-20 |
2006-02-24 |
Nuevolution As |
Templated molecules and methods for using such molecules
|
US7727713B2
(en)
|
2001-06-20 |
2010-06-01 |
Nuevolution A/S |
Templated molecules and methods for using such molecules
|
WO2004001042A2
(en)
*
|
2002-06-20 |
2003-12-31 |
Nuevolution A/S |
Microarrays displaying encoded molecules
|
US20040161741A1
(en)
|
2001-06-30 |
2004-08-19 |
Elazar Rabani |
Novel compositions and processes for analyte detection, quantification and amplification
|
US9777312B2
(en)
|
2001-06-30 |
2017-10-03 |
Enzo Life Sciences, Inc. |
Dual polarity analysis of nucleic acids
|
US20030143612A1
(en)
*
|
2001-07-18 |
2003-07-31 |
Pointilliste, Inc. |
Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
|
CA2456105A1
(en)
*
|
2001-07-31 |
2003-02-13 |
Phylos, Inc. |
Modular assembly of nucleic acid-protein fusion multimers
|
US7172905B2
(en)
|
2001-08-07 |
2007-02-06 |
The University Of Chicago |
Polypeptide immobilization
|
DE10147074A1
(de)
*
|
2001-09-25 |
2003-05-08 |
Beru Ag |
Verfahren zum Betreiben einer aus mehreren Heizelementen bestehenden mehrstufigen elektrischen Heizung
|
GB0127564D0
(en)
|
2001-11-16 |
2002-01-09 |
Medical Res Council |
Emulsion compositions
|
DE60232688D1
(de)
|
2001-11-20 |
2009-07-30 |
Univ Duke |
Grenzflächen-biomaterialien
|
US7125669B2
(en)
*
|
2001-11-27 |
2006-10-24 |
Compound Therapeutics, Inc. |
Solid-phase immobilization of proteins and peptides
|
US7262054B2
(en)
*
|
2002-01-22 |
2007-08-28 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
DE20200926U1
(de)
*
|
2002-01-23 |
2002-04-18 |
Hegenscheidt Mfd Gmbh & Co Kg |
Festwalzgerät einer Festwalzmaschine für Kurbelwellen
|
JP2003299489A
(ja)
*
|
2002-02-08 |
2003-10-21 |
Mitsubishi Chemicals Corp |
核酸構築物
|
NO20021298L
(no)
*
|
2002-03-15 |
2003-09-16 |
Bjoern H Lindqvist |
Metoder for peptid og protein påvisning i nukleinsyre chip- arrays
|
AU2003253069A1
(en)
*
|
2002-03-15 |
2003-09-29 |
Nuevolution A/S |
A building block forming a c-c bond upon reaction
|
DK1487978T3
(da)
|
2002-03-15 |
2009-03-23 |
Nuevolution As |
Forbedret fremgangsmåde til syntese af templatemolekyler
|
EP1487849A2
(de)
*
|
2002-03-15 |
2004-12-22 |
Nuevolution A/S |
Ein baublock geeignet zur funktionellen gruppe übertragung
|
EP1487850A2
(de)
*
|
2002-03-15 |
2004-12-22 |
Nuevolution A/S |
Ein baublock zur c-c bindungsbildung oder c-heteroatom bindungsbildung
|
US20030235851A1
(en)
*
|
2002-04-19 |
2003-12-25 |
Roberts Richard W. |
Methods of using sense and/or nonsense suppression to make nucleic acid-peptide display libraries containing peptides with unnatural amino acid residues
|
US20030198967A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Matson Robert S. |
Multi-functional microarrays and methods
|
US20030198973A1
(en)
*
|
2002-04-23 |
2003-10-23 |
The Molecular Sciences Institute, Inc. |
Chimeric fusion molecule for analyte detection and quantitation
|
US20060073481A1
(en)
*
|
2002-04-23 |
2006-04-06 |
The Molecular Sciences Institute |
Formation and use of site specific nucleic acid coupled binding polypeptides
|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
EP1521961A2
(de)
*
|
2002-07-05 |
2005-04-13 |
The University of Chicago |
Charakterisierung von biochips mit selbstausgerichteten monoschichten mittels maldi-tof-ms
|
USRE47770E1
(en)
|
2002-07-18 |
2019-12-17 |
Merus N.V. |
Recombinant production of mixtures of antibodies
|
PT2314629E
(pt)
*
|
2002-07-18 |
2014-01-22 |
Merus B V |
Produção recombinante de misturas de anticorpos
|
AU2003247266A1
(en)
|
2002-08-01 |
2004-02-23 |
Nuevolution A/S |
Multi-step synthesis of templated molecules
|
AU2003263937B2
(en)
*
|
2002-08-19 |
2010-04-01 |
The President And Fellows Of Harvard College |
Evolving new molecular function
|
US20040043384A1
(en)
*
|
2002-08-28 |
2004-03-04 |
Oleinikov Andrew V. |
In vitro protein translation microarray device
|
US7361635B2
(en)
*
|
2002-08-29 |
2008-04-22 |
Sangamo Biosciences, Inc. |
Simultaneous modulation of multiple genes
|
EP1585970A4
(de)
*
|
2002-10-18 |
2008-08-06 |
Promega Corp |
Verfahren zur trennung von molek len
|
DK2348124T3
(en)
|
2002-10-30 |
2014-03-10 |
Nuevolution As |
Synthesis of a bifunctional complex
|
AU2011226815B2
(en)
*
|
2002-10-30 |
2014-09-25 |
Nuevolution A/S |
Enzymatic encoding
|
WO2004056994A2
(en)
|
2002-12-19 |
2004-07-08 |
Nuevolution A/S |
Quasirandom structure and function guided synthesis methods
|
US7083948B1
(en)
*
|
2002-12-24 |
2006-08-01 |
Immunex Corporation |
Polypeptide purification reagents and methods for their use
|
AU2004254552B2
(en)
|
2003-01-29 |
2008-04-24 |
454 Life Sciences Corporation |
Methods of amplifying and sequencing nucleic acids
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
KR100858081B1
(ko)
*
|
2003-02-14 |
2008-09-10 |
삼성전자주식회사 |
유전정보 코딩장치 및 방법
|
US20070026397A1
(en)
|
2003-02-21 |
2007-02-01 |
Nuevolution A/S |
Method for producing second-generation library
|
US20060269920A1
(en)
*
|
2003-02-21 |
2006-11-30 |
Nuevolution A/S |
Method for obtaining structural information about an encoded molecule
|
DK1608748T3
(da)
|
2003-03-20 |
2009-06-29 |
Nuevolution As |
Ligeringskodning af små molekyler
|
US8017323B2
(en)
*
|
2003-03-26 |
2011-09-13 |
President And Fellows Of Harvard College |
Free reactant use in nucleic acid-templated synthesis
|
WO2004087730A2
(en)
*
|
2003-03-27 |
2004-10-14 |
The Johns Hopkins University |
Method for producing diverse libraries of encoded polymers
|
GB0307428D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
GB0307403D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
US20050079546A1
(en)
*
|
2003-05-01 |
2005-04-14 |
Dasa Lipovsek |
Serum albumin scaffold-based proteins and uses thereof
|
ES2408582T3
(es)
|
2003-05-30 |
2013-06-21 |
Merus B.V. |
Biblioteca de Fab para la preparación de una mezcla de anticuerpos
|
US20100069614A1
(en)
|
2008-06-27 |
2010-03-18 |
Merus B.V. |
Antibody producing non-human mammals
|
WO2004110964A2
(en)
*
|
2003-06-16 |
2004-12-23 |
Nuevolution A/S |
Encoded molecules by translation (emt)
|
EP2918595B1
(de)
|
2003-07-05 |
2019-12-11 |
The Johns-Hopkins University |
Verfahren und Zusammensetzungen zur Detektion und Zählung von genetischen Variationen
|
ES2458636T3
(es)
|
2003-08-18 |
2014-05-06 |
Medimmune, Llc |
Humanización de anticuerpos
|
WO2005026387A1
(en)
|
2003-09-18 |
2005-03-24 |
Nuevolution A/S |
A method for obtaining structural information concerning an encoded molecule and method for selecting compounds
|
KR20060129246A
(ko)
|
2003-12-05 |
2006-12-15 |
컴파운드 쎄라퓨틱스, 인크. |
타입 2 혈관 내피 성장 인자 수용체의 억제제
|
US20080220049A1
(en)
*
|
2003-12-05 |
2008-09-11 |
Adnexus, A Bristol-Myers Squibb R&D Company |
Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
|
EP1737971B1
(de)
|
2004-01-20 |
2017-08-16 |
Merus N.V. |
Gemische bindender proteine
|
EP1723255B1
(de)
*
|
2004-02-17 |
2010-12-29 |
Nuevolution A/S |
Anreicherungsverfahren mit eliminierung durch fehlpaarungshybridisierung
|
EP1730277B1
(de)
|
2004-03-22 |
2009-10-28 |
Nuevolution A/S |
Ligationscodierung unter verwendung von oligonukleotidbausteinen
|
US20050221339A1
(en)
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
US20060008844A1
(en)
|
2004-06-17 |
2006-01-12 |
Avidia Research Institute |
c-Met kinase binding proteins
|
JP5053089B2
(ja)
*
|
2004-08-03 |
2012-10-17 |
ベクトン・ディキンソン・アンド・カンパニー |
化合物の直接単離および多成分サンプルの分別のための磁性材料の使用
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
EP1836302B1
(de)
*
|
2004-12-23 |
2010-04-14 |
Amersham Biosciences Corp. |
Rna-amplifikation auf ligationsbasis
|
JP2008526973A
(ja)
*
|
2005-01-12 |
2008-07-24 |
プロテオノヴァ、 インコーポレイテッド |
標的治療薬を作製する方法
|
US10206998B2
(en)
|
2005-01-12 |
2019-02-19 |
Proteonova, Inc. |
Modular targeted therapeutic agents and methods of making same
|
JP5153613B2
(ja)
|
2005-03-18 |
2013-02-27 |
メディミューン,エルエルシー |
抗体のフレームワーク・シャッフル
|
WO2007011722A2
(en)
|
2005-07-15 |
2007-01-25 |
President And Fellows Of Harvard College |
Reaction discovery system
|
EP2500355A3
(de)
|
2005-08-19 |
2012-10-24 |
Abbott Laboratories |
Immunglobuline mit zweifacher variabler Domäne und ihre Verwendung
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
SG2014010029A
(en)
|
2005-08-19 |
2014-08-28 |
Abbott Lab |
Dual variable domain immunoglobin and uses thereof
|
US8906864B2
(en)
|
2005-09-30 |
2014-12-09 |
AbbVie Deutschland GmbH & Co. KG |
Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use
|
RU2008123606A
(ru)
|
2005-11-11 |
2009-12-20 |
Вертекс Фармасьютикалз, Инк (Us) |
Варианты вируса гепатита с
|
EP1785434A1
(de)
|
2005-11-11 |
2007-05-16 |
Ludwig-Maximilians-Universität München |
Zielen und Folgen von Antigenen in lebenden Zellen
|
US7705138B2
(en)
*
|
2005-11-11 |
2010-04-27 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
CA2626522A1
(en)
|
2005-11-16 |
2007-05-24 |
Ambrx, Inc. |
Methods and compositions comprising non-natural amino acids
|
AU2006319358B2
(en)
|
2005-11-30 |
2012-01-19 |
AbbVie Deutschland GmbH & Co. KG |
Anti-Abeta globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
|
RS53270B2
(sr)
|
2005-11-30 |
2018-05-31 |
Abbvie Deutschland |
Monoklonalna antitela protiv amiloidnog beta proteina i njihova upotreba
|
EP2341140B1
(de)
|
2005-12-01 |
2017-07-19 |
Nuevolution A/S |
Enzymvermittelnde Kodierungsmethoden für eine effiziente Synthese von grossen Bibliotheken
|
US20080305559A1
(en)
*
|
2005-12-15 |
2008-12-11 |
Gualberto Gonzalez-Sapienza |
Non-Competitive Immunoassays to Detect Small Molecules
|
EP2363205A3
(de)
|
2006-01-11 |
2014-06-04 |
Raindance Technologies, Inc. |
Mikrofluidische Vorrichtungen Und Verfahren Zur Verwendung Bei Der Bildung Und Kontrolle Von Nanoreaktoren
|
SI1994171T1
(sl)
*
|
2006-01-17 |
2015-07-31 |
Somalogic, Inc. |
Multipleksirane analize testnih vzorcev
|
MX2008009792A
(es)
|
2006-02-01 |
2008-09-01 |
Arana Therapeutics Ltd |
Construccion de anticuerpo de dominio.
|
WO2007092777A2
(en)
*
|
2006-02-02 |
2007-08-16 |
Wyeth |
Cloning, characterization, and application of tnfrsf19 in neurological disorders
|
US7749957B2
(en)
|
2006-04-06 |
2010-07-06 |
E.I. Du Pont De Nemours And Company |
Clay-binding peptides and methods of use
|
EP2530168B1
(de)
|
2006-05-11 |
2015-09-16 |
Raindance Technologies, Inc. |
Mikrofluidische Vorrichtungen
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
US8178316B2
(en)
|
2006-06-29 |
2012-05-15 |
President And Fellows Of Harvard College |
Evaluating proteins
|
KR20090034930A
(ko)
*
|
2006-06-30 |
2009-04-08 |
암비트 바이오사이언시즈 코포레이션 |
탐지 가능한 핵산 태그
|
US7572618B2
(en)
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
JP2009545747A
(ja)
*
|
2006-08-02 |
2009-12-24 |
カリフォルニア インスティチュート オブ テクノロジー |
標的を検出及び/又は選別する方法並びにシステム
|
WO2008021123A1
(en)
|
2006-08-07 |
2008-02-21 |
President And Fellows Of Harvard College |
Fluorocarbon emulsion stabilizing surfactants
|
MY188368A
(en)
|
2006-09-08 |
2021-12-06 |
Abbott Lab |
Interleukin-13 binding proteins
|
US20090252745A1
(en)
*
|
2006-09-15 |
2009-10-08 |
Duke University |
Amino acids in the HCV core polypeptide domain 3 and correlation with steatosis
|
KR20090110295A
(ko)
|
2006-11-22 |
2009-10-21 |
에드넥서스, 어 브리스톨-마이어스 스퀴브 알&디 컴파니 |
Igf-ir을 포함하는 티로신 키나제 수용체에 대한 공학처리된 단백질에 기반한 표적화 치료제
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
US8324350B2
(en)
|
2006-12-29 |
2012-12-04 |
Abbott Laboratories |
Dual-specific IL-1α/IL-1β antibodies
|
US20110136099A1
(en)
|
2007-01-16 |
2011-06-09 |
Somalogic, Inc. |
Multiplexed Analyses of Test Samples
|
US7855054B2
(en)
*
|
2007-01-16 |
2010-12-21 |
Somalogic, Inc. |
Multiplexed analyses of test samples
|
WO2008097497A2
(en)
|
2007-02-02 |
2008-08-14 |
Adnexus, A Bristol-Myers Squibb R & D Company |
Vegf pathway blockade
|
WO2008097559A2
(en)
|
2007-02-06 |
2008-08-14 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
AU2008216303A1
(en)
|
2007-02-12 |
2008-08-21 |
Proteonova, Inc. |
Generation of library of soluble random polypeptides linked to mRNA
|
EP2486928A1
(de)
|
2007-02-27 |
2012-08-15 |
Abbott GmbH & Co. KG |
Verfahren zur Behandlung von Amyloidosen
|
WO2008130623A1
(en)
|
2007-04-19 |
2008-10-30 |
Brandeis University |
Manipulation of fluids, fluid components and reactions in microfluidic systems
|
US7829311B2
(en)
|
2007-07-25 |
2010-11-09 |
E.I. Du Pont De Nemours And Company |
Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
|
US7678883B2
(en)
*
|
2007-07-25 |
2010-03-16 |
E.I. Du Pont De Nemours And Company |
Solubility tags for the expression and purification of bioactive peptides
|
US7951559B2
(en)
*
|
2007-07-25 |
2011-05-31 |
E.I. Du Pont De Nemours And Company |
Recombinant peptide production using a cross-linkable solubility tag
|
US8680019B2
(en)
*
|
2007-08-10 |
2014-03-25 |
Protelica, Inc. |
Universal fibronectin Type III binding-domain libraries
|
JP5781762B2
(ja)
*
|
2007-08-10 |
2015-09-24 |
プロテリックス、インク |
ユニバーサルiii型フィブロネクチン結合ドメインのライブラリ
|
US8470966B2
(en)
|
2007-08-10 |
2013-06-25 |
Protelica, Inc. |
Universal fibronectin type III binding-domain libraries
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
WO2009036379A2
(en)
|
2007-09-14 |
2009-03-19 |
Adimab, Inc. |
Rationally designed, synthetic antibody libraries and uses therefor
|
US7794963B2
(en)
|
2007-11-02 |
2010-09-14 |
E.I. Du Pont De Nemours And Company |
Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
|
AU2008320823B2
(en)
|
2007-11-02 |
2013-01-17 |
Novartis Ag |
Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (LRP6)
|
US8906700B2
(en)
|
2007-11-06 |
2014-12-09 |
Ambergen, Inc. |
Methods and compositions for phototransfer
|
AU2008334099B2
(en)
|
2007-11-30 |
2014-07-24 |
Abbvie Biotechnology Ltd. |
Protein formulations and methods of making same
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
US8716437B2
(en)
*
|
2007-12-07 |
2014-05-06 |
Steven A. Goldstein |
Identification of toxin ligands
|
AU2009213141A1
(en)
|
2008-02-14 |
2009-08-20 |
Bristol-Myers Squibb Company |
Targeted therapeutics based on engineered proteins that bind EGFR
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
WO2009114815A1
(en)
|
2008-03-13 |
2009-09-17 |
Dyax Corp |
Libraries of genetic packages comprising novel hc cdr3 designs
|
JP5774471B2
(ja)
|
2008-03-27 |
2015-09-09 |
プロメガ コーポレイションPromega Corporation |
シアノベンゾチアゾールコンジュゲートによるタンパク質標識
|
EP2281078B1
(de)
*
|
2008-04-24 |
2014-10-22 |
Dyax Corporation |
Bibliotheken von genetischen packungen, umfassend neue hc-cdr1, -cdr2, und -cdr3, und neue lc-cdr1-, -cdr2- und -cdr3-designs
|
KR101634719B1
(ko)
|
2008-04-25 |
2016-06-29 |
다이액스 코포레이션 |
Fcrn에 대한 항체 및 이들의 용도
|
EP2282769A4
(de)
|
2008-04-29 |
2012-04-25 |
Abbott Lab |
Dual-variable- domain-immunglobuline und ihre verwendungen
|
JP2011521626A
(ja)
|
2008-05-02 |
2011-07-28 |
エピセンター テクノロジーズ コーポレーション |
Rnaポリホスファターゼの組成物、キットおよびそれらの使用
|
ES2579554T3
(es)
|
2008-05-09 |
2016-08-12 |
Abbvie Deutschland Gmbh & Co Kg |
Anticuerpos para el receptor de productos terminales de glicación avanzada (RAGE) y usos de los mismos
|
PE20091931A1
(es)
|
2008-05-22 |
2009-12-31 |
Bristol Myers Squibb Co |
Proteinas de dominio de armazon basadas en fibronectina multivalentes
|
CA2725666A1
(en)
|
2008-06-03 |
2009-12-10 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
RU2010153580A
(ru)
|
2008-06-03 |
2012-07-20 |
Эбботт Лэборетриз (Us) |
Иммуноглобулины с двумя вариабельными доменами и их применение
|
MX2011000006A
(es)
|
2008-06-30 |
2011-08-03 |
Esbatech Alcon Biomed Res Unit |
Polipeptidos funcionalizados.
|
CN104829718A
(zh)
|
2008-07-08 |
2015-08-12 |
艾伯维公司 |
前列腺素e2结合蛋白及其用途
|
JP5674654B2
(ja)
|
2008-07-08 |
2015-02-25 |
アッヴィ・インコーポレイテッド |
プロスタグランジンe2二重可変ドメイン免疫グロブリンおよびその使用
|
EP4047367A1
(de)
|
2008-07-18 |
2022-08-24 |
Bio-Rad Laboratories, Inc. |
Verfahren zum nachweis von zielanalyten unter verwendung von tropfenbibliotheken
|
EP3629022A1
(de)
|
2008-07-25 |
2020-04-01 |
Richard W. Wagner |
Proteinscreeningverfahren
|
MX2011003380A
(es)
*
|
2008-09-30 |
2011-04-21 |
Abbott Lab |
Genotecas de anticuerpo mejoradas.
|
EP2349329A4
(de)
|
2008-10-14 |
2012-10-31 |
Dyax Corp |
Verwendung von igf-ii/igf-iie-bindung zur behandlung und prävention von systemischer sklerose im zusammenhang mit lungenfibrose
|
TWI496582B
(zh)
|
2008-11-24 |
2015-08-21 |
必治妥美雅史谷比公司 |
雙重專一性之egfr/igfir結合分子
|
US20100158822A1
(en)
*
|
2008-12-18 |
2010-06-24 |
E .I. Du Pont De Nemours And Company |
Peptides that bind to silica-coated particles
|
US20100158837A1
(en)
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Iron oxide-binding peptides
|
US20100158846A1
(en)
*
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Hair-binding peptides
|
US8287845B2
(en)
*
|
2008-12-18 |
2012-10-16 |
E I Du Pont De Nemours And Company |
Hair-binding peptides
|
US8697654B2
(en)
|
2008-12-18 |
2014-04-15 |
E I Du Pont De Nemours And Company |
Peptide linkers for effective multivalent peptide binding
|
CN101768213B
(zh)
|
2008-12-30 |
2012-05-30 |
中国科学院遗传与发育生物学研究所 |
一种与植物分蘖数目相关的蛋白及其编码基因与应用
|
EA021797B1
(ru)
|
2009-02-13 |
2015-09-30 |
Икс-Чем, Инк. |
Способы создания и скрининга библиотек, кодируемых днк
|
CN101817879A
(zh)
|
2009-02-26 |
2010-09-01 |
中国科学院遗传与发育生物学研究所 |
金属硫蛋白及其编码基因与应用
|
US8835610B2
(en)
|
2009-03-05 |
2014-09-16 |
Abbvie Inc. |
IL-17 binding proteins
|
EP3415235A1
(de)
|
2009-03-23 |
2018-12-19 |
Raindance Technologies Inc. |
Manipulation von mikrofluidiktröpfchen
|
US8481678B2
(en)
|
2009-03-30 |
2013-07-09 |
E I Du Pont De Nemours And Company |
Peptide-based tooth whitening reagents
|
US20100247590A1
(en)
*
|
2009-03-30 |
2010-09-30 |
Johnson & Johnson |
Peptide-Based Systems For Delivery Of Cosmetic Agents
|
US8067201B2
(en)
|
2009-04-17 |
2011-11-29 |
Bristol-Myers Squibb Company |
Methods for protein refolding
|
EP2421989B1
(de)
|
2009-04-24 |
2015-10-14 |
DiscoveRx Corporation |
Zelltestverfahren unter einsatz von nachweisbarem protein
|
WO2010127186A1
(en)
|
2009-04-30 |
2010-11-04 |
Prognosys Biosciences, Inc. |
Nucleic acid constructs and methods of use
|
PE20121647A1
(es)
|
2009-08-29 |
2012-12-31 |
Abbvie Inc |
Proteinas terapeuticas de union a dll4
|
TW201119673A
(en)
|
2009-09-01 |
2011-06-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
CA2773564A1
(en)
|
2009-09-14 |
2011-03-17 |
Dyax Corp. |
Libraries of genetic packages comprising novel hc cdr3 designs
|
JP2013506435A
(ja)
*
|
2009-10-05 |
2013-02-28 |
オプソニック セラピューティクス インコーポレイテッド |
抗体特異性をリダイレクトするための高親和性アダプター分子
|
WO2011042564A1
(en)
|
2009-10-09 |
2011-04-14 |
Universite De Strasbourg |
Labelled silica-based nanomaterial with enhanced properties and uses thereof
|
TW201119676A
(en)
|
2009-10-15 |
2011-06-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
WO2011049157A1
(ja)
|
2009-10-22 |
2011-04-28 |
ペプチドリーム株式会社 |
ペプチド翻訳合成におけるrapidディスプレイ法
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
ES2691717T3
(es)
|
2009-10-30 |
2018-11-28 |
Novartis Ag |
Bibliotecas universales del dominio de unión del lado inferior de tipo iii de la fibronectina de tipo III
|
WO2011053707A1
(en)
|
2009-10-31 |
2011-05-05 |
Abbott Laboratories |
Antibodies to receptor for advanced glycation end products (rage) and uses thereof
|
CN102640001A
(zh)
|
2009-11-05 |
2012-08-15 |
诺瓦提斯公司 |
预测纤维化进展的生物标记物
|
US9244063B2
(en)
|
2009-11-11 |
2016-01-26 |
Gentian As |
Immunoassay for assessing related analytes of different origin
|
MX2012006397A
(es)
|
2009-12-02 |
2012-11-30 |
Amgen Inc |
PROTEINAS DE ENLACE QUE ENLAZAN A FGFR1C HUMANO, ß-KLOTHO HUMANA Y TANTO FGFR1C HUMANO COMO ß-KLOTHO HUMANA.
|
EP2510127B1
(de)
*
|
2009-12-07 |
2015-06-10 |
Prognosys Biosciences, Inc. |
Peptidanzeigearrays
|
CA2780069C
(en)
|
2009-12-08 |
2018-07-17 |
Abbott Gmbh & Co. Kg |
Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration
|
EP2517025B1
(de)
|
2009-12-23 |
2019-11-27 |
Bio-Rad Laboratories, Inc. |
Verfahren zur reduzierung des austauschs von molekülen zwischen tröpfchen
|
WO2011085103A2
(en)
|
2010-01-06 |
2011-07-14 |
Dyax Corp. |
Plasma kallikrein binding proteins
|
MX2012009318A
(es)
|
2010-02-10 |
2012-09-07 |
Novartis Ag |
Metodos y compuestos para el crecimiento muscular.
|
EP2534267B1
(de)
|
2010-02-12 |
2018-04-11 |
Raindance Technologies, Inc. |
Digitale analyse von analyten
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
CN102762591A
(zh)
|
2010-02-18 |
2012-10-31 |
百时美施贵宝公司 |
结合il-23的基于纤连蛋白的支架结构域蛋白质
|
SG10201501562VA
(en)
|
2010-03-02 |
2015-04-29 |
Abbvie Inc |
Therapeutic dll4 binding proteins
|
US10787701B2
(en)
|
2010-04-05 |
2020-09-29 |
Prognosys Biosciences, Inc. |
Spatially encoded biological assays
|
JP5893607B2
(ja)
|
2010-04-05 |
2016-03-23 |
プログノシス バイオサイエンシズ インコーポレイテッドPrognosys Biosciences,Inc. |
空間コード化生物学的アッセイ
|
US20190300945A1
(en)
|
2010-04-05 |
2019-10-03 |
Prognosys Biosciences, Inc. |
Spatially Encoded Biological Assays
|
US8420098B2
(en)
|
2010-04-13 |
2013-04-16 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domain proteins that bind to PCSK9
|
MX336196B
(es)
|
2010-04-15 |
2016-01-11 |
Abbvie Inc |
Proteinas de union a amiloide beta.
|
LT2558577T
(lt)
|
2010-04-16 |
2019-03-12 |
Nuevolution A/S |
Bifunkciniai kompleksai ir tokių kompleksų gamybos ir naudojimo būdai
|
TW201138808A
(en)
|
2010-05-03 |
2011-11-16 |
Bristol Myers Squibb Co |
Serum albumin binding molecules
|
HUE033063T2
(hu)
|
2010-05-14 |
2017-11-28 |
Abbvie Inc |
IL-1 kötõ fehérjék
|
WO2011150133A2
(en)
|
2010-05-26 |
2011-12-01 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold proteins having improved stability
|
US20120009196A1
(en)
|
2010-07-08 |
2012-01-12 |
Abbott Laboratories |
Monoclonal antibodies against hepatitis c virus core protein
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
DK3741883T3
(da)
|
2010-07-16 |
2023-02-20 |
Adimab Llc |
Antistofbiblioteker
|
WO2012016245A2
(en)
|
2010-07-30 |
2012-02-02 |
Novartis Ag |
Fibronectin cradle molecules and libraries thereof
|
CA2807014A1
(en)
|
2010-08-03 |
2012-02-09 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
WO2012024187A1
(en)
|
2010-08-14 |
2012-02-23 |
Abbott Laboratories |
Amyloid-beta binding proteins
|
US9505829B2
(en)
|
2010-08-19 |
2016-11-29 |
Zoetis Belgium S.A. |
Anti-NGF antibodies and their use
|
CA2809433A1
(en)
|
2010-08-26 |
2012-03-01 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
US9562897B2
(en)
|
2010-09-30 |
2017-02-07 |
Raindance Technologies, Inc. |
Sandwich assays in droplets
|
EP4108671A1
(de)
|
2010-10-01 |
2022-12-28 |
ModernaTX, Inc. |
Modifizierte nukleoside, nukleotide und nukleinsäuren und ihre verwendungen
|
WO2012052391A1
(en)
|
2010-10-19 |
2012-04-26 |
Glaxo Group Limited |
Polypeptide with jmjd3 catalytic activity
|
EP3130605B1
(de)
|
2010-11-05 |
2020-01-08 |
Eisai Inc. |
Folatrezeptor-alpha als diagnostischer und prognostischer marker für folatrezeptor-alpha-exprimierende karzinome
|
JP6004399B2
(ja)
|
2010-12-03 |
2016-10-05 |
国立大学法人 東京大学 |
安定化された二次構造を有するペプチド、及びペプチドライブラリー、それらの製造方法
|
US10195578B2
(en)
|
2010-12-03 |
2019-02-05 |
The University Of Tokyo |
Peptide library production method, peptide library, and screening method
|
US20120275996A1
(en)
|
2010-12-21 |
2012-11-01 |
Abbott Laboratories |
IL-1 Binding Proteins
|
RU2627171C2
(ru)
|
2010-12-21 |
2017-08-03 |
Эббви Инк. |
Il-1 альфа и бета биспецифические иммуноглобулины с двойными вариабельными доменами и их применение
|
EP2655411A1
(de)
|
2010-12-22 |
2013-10-30 |
Bristol-Myers Squibb Company |
Fibronectin-gerüstdomänen-proteine zur bindung von il-23
|
DE102010056289A1
(de)
|
2010-12-24 |
2012-06-28 |
Geneart Ag |
Verfahren zur Herstellung von Leseraster-korrekten Fragment-Bibliotheken
|
US9364803B2
(en)
|
2011-02-11 |
2016-06-14 |
Raindance Technologies, Inc. |
Methods for forming mixed droplets
|
US9150852B2
(en)
|
2011-02-18 |
2015-10-06 |
Raindance Technologies, Inc. |
Compositions and methods for molecular labeling
|
US9746475B2
(en)
|
2011-03-14 |
2017-08-29 |
University Of Southern California |
Antibody and antibody mimetic for visualization and ablation of endogenous proteins
|
ES2873375T3
(es)
|
2011-03-15 |
2021-11-03 |
X Body Inc |
Métodos de cribado de anticuerpos
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
WO2012139110A2
(en)
|
2011-04-08 |
2012-10-11 |
Prognosys Biosciences, Inc. |
Peptide constructs and assay systems
|
ES2942455T3
(es)
|
2011-04-13 |
2023-06-01 |
Bristol Myers Squibb Co |
Proteínas de fusión Fc que comprenden enlazadores o disposiciones nuevos
|
GB201106254D0
(en)
|
2011-04-13 |
2011-05-25 |
Frisen Jonas |
Method and product
|
KR102151656B1
(ko)
|
2011-04-28 |
2020-09-03 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
샘플과 연관된 폴리뉴클레오티드의 식별
|
EP2709669A1
(de)
|
2011-05-17 |
2014-03-26 |
Bristol-Myers Squibb Company |
Verfahren zur aufrechterhaltung der pegylierung von polypeptiden
|
US9347058B2
(en)
|
2011-05-17 |
2016-05-24 |
Bristol-Myers Squibb Company |
Methods for the selection of binding proteins
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
EP3709018A1
(de)
|
2011-06-02 |
2020-09-16 |
Bio-Rad Laboratories, Inc. |
Mikrofluidische vorrichtung zum nachweis von komponenten einer chemischen reaktion
|
EP2966089B1
(de)
|
2011-06-02 |
2020-03-25 |
Dyax Corp. |
Fc-rezeptor-bindende proteine
|
JP2014516551A
(ja)
|
2011-06-02 |
2014-07-17 |
マサチューセッツ インスティテュート オブ テクノロジー |
メタカリオート(metakaryotic)幹細胞のdsRNA/DNAハイブリッドゲノム複製中間体
|
MX2014000531A
(es)
|
2011-07-13 |
2014-12-05 |
Abbvie Inc |
Metodos y composiciones para el tratamiento del asma usando anticuerpos anti-il-13.
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
CA2843955A1
(en)
|
2011-08-01 |
2013-02-07 |
The General Hospital Corporation |
Protein and peptide libraries
|
CA2848023C
(en)
|
2011-09-07 |
2022-03-15 |
X-Chem, Inc. |
Methods for tagging dna-encoded libraries
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
CN103974724B
(zh)
|
2011-10-03 |
2019-08-30 |
现代泰克斯公司 |
修饰的核苷、核苷酸和核酸及其用途
|
WO2013063114A1
(en)
|
2011-10-24 |
2013-05-02 |
Abbvie Inc. |
Immunobinders directed against tnf
|
AR088513A1
(es)
|
2011-10-24 |
2014-06-18 |
Abbvie Inc |
Inmunoenlazantes dirigidos contra esclerostina
|
US9522951B2
(en)
|
2011-10-31 |
2016-12-20 |
Bristol-Myers Squibb Company |
Fibronectin binding domains with reduced immunogenicity
|
EP2788379B1
(de)
|
2011-12-05 |
2020-02-05 |
X-Body, Inc. |
Pdgf-rezeptor beta bindende polypeptide
|
US10118958B2
(en)
|
2011-12-14 |
2018-11-06 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
CA2855570A1
(en)
|
2011-12-14 |
2013-06-20 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
CA2859387A1
(en)
|
2011-12-16 |
2013-06-20 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
EP3974563A1
(de)
|
2011-12-28 |
2022-03-30 |
Chugai Seiyaku Kabushiki Kaisha |
Zyklische peptide
|
BR112014015851A2
(pt)
|
2011-12-30 |
2019-09-24 |
Abbvie Inc |
proteínas de ligação específicas duplas direcionadas contra il-13 e/ou il-17
|
ES2676725T3
(es)
|
2012-01-27 |
2018-07-24 |
AbbVie Deutschland GmbH & Co. KG |
Composición y método para el diagnóstico y el tratamiento de enfermedades asociadas con la degeneración de las neuritas
|
GB2500243A
(en)
*
|
2012-03-15 |
2013-09-18 |
Isogenica Ltd |
Identifying members of immobilised peptide libraries comprising protein-DNA complexes
|
AU2013243951A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of secreted proteins
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
HUE045944T2
(hu)
|
2012-04-20 |
2020-02-28 |
Merus Nv |
Eljárások és eszközök heterodimerikus IG-szerû molekulák elõállítására
|
US9238676B2
(en)
|
2012-05-17 |
2016-01-19 |
Ra Pharmaceuticals, Inc. |
Peptide and peptidomimetic inhibitors
|
JP6629069B2
(ja)
|
2012-06-06 |
2020-01-15 |
ゾエティス・エルエルシー |
イヌ化抗ngf抗体およびその方法
|
US9670276B2
(en)
|
2012-07-12 |
2017-06-06 |
Abbvie Inc. |
IL-1 binding proteins
|
NZ703766A
(en)
|
2012-07-13 |
2018-03-23 |
X Chem Inc |
Dna-encoded libraries having encoding oligonucleotide linkages not readable by polymerases
|
EP3564258B1
(de)
|
2012-09-13 |
2021-04-28 |
Bristol-Myers Squibb Company |
Fibronectinbasierte gerüstdomänenproteine zur bindung an myostatin
|
SG11201503412RA
(en)
|
2012-11-01 |
2015-05-28 |
Abbvie Inc |
Anti-vegf/dll4 dual variable domain immunoglobulins and uses thereof
|
JP6144355B2
(ja)
|
2012-11-26 |
2017-06-07 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
化学修飾mRNA
|
US9550986B2
(en)
|
2012-12-21 |
2017-01-24 |
Abbvie Inc. |
High-throughput antibody humanization
|
EP2952582A4
(de)
|
2013-01-30 |
2016-11-16 |
Peptidream Inc |
Flexibles anzeigeverfahren
|
US20150361159A1
(en)
|
2013-02-01 |
2015-12-17 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold proteins
|
WO2014124017A1
(en)
|
2013-02-06 |
2014-08-14 |
Bristol-Myers Squibb Company |
Fibronectin type iii domain proteins with enhanced solubility
|
EP3299378B1
(de)
|
2013-02-12 |
2019-07-31 |
Bristol-Myers Squibb Company |
Rückfaltungsverfahren für protein mit hohem ph-wert
|
CA3175634A1
(en)
|
2013-02-28 |
2014-09-04 |
Caprion Proteomics Inc. |
Tuberculosis biomarkers and uses thereof
|
EP2968587A2
(de)
|
2013-03-13 |
2016-01-20 |
Bristol-Myers Squibb Company |
Serumalbumingebundene fibronectin-gerüstdomänen oder daran bindendes element
|
JP6739329B2
(ja)
|
2013-03-14 |
2020-08-12 |
アボット・ラボラトリーズAbbott Laboratories |
Hcvコア脂質結合ドメインモノクローナル抗体
|
WO2014159961A1
(en)
|
2013-03-14 |
2014-10-02 |
Beth Israel Deaconess Medical Center, Inc. |
Measurement of fgf21 as a biomarker of fructose metabolism and metabolic disease
|
BR112015023239A8
(pt)
|
2013-03-14 |
2018-04-17 |
Abbott Lab |
ensaio de combinação de anticorpo-antígeno de hcv e métodos e composições para uso do mesmo
|
MX2015012824A
(es)
|
2013-03-14 |
2016-06-24 |
Abbott Lab |
Antigenos recombinantes ns3 del vhc y mutantes de los mismos para la deteccion mejorada de anticuerpos.
|
CN105324396A
(zh)
|
2013-03-15 |
2016-02-10 |
艾伯维公司 |
针对IL-1β和/或IL-17的双重特异性结合蛋白
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
US11231419B2
(en)
|
2013-03-15 |
2022-01-25 |
Prognosys Biosciences, Inc. |
Methods for detecting peptide/MHC/TCR binding
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
EP2999796B1
(de)
|
2013-05-20 |
2017-10-25 |
BioVentures, LLC |
Gep5-modell für multiples myelom
|
JP6581572B2
(ja)
|
2013-06-07 |
2019-09-25 |
デューク ユニバーシティ |
補体因子h阻害薬
|
WO2014210225A1
(en)
|
2013-06-25 |
2014-12-31 |
Prognosys Biosciences, Inc. |
Methods and systems for determining spatial patterns of biological targets in a sample
|
RU2678421C2
(ru)
|
2013-06-28 |
2019-01-28 |
Экс-Боди, Инк. |
Обнаружение антигена-мишени, фенотипический скрининг и его применение для идентификации специфичных эпитопов-мишеней клеток-мишеней
|
EP3041934A1
(de)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Chimäre polynukleotide
|
EP3049811B1
(de)
|
2013-09-23 |
2020-09-09 |
X-Body, Inc. |
Verfahren und zusammensetzungen zur erzeugung von bindemitteln gegen zelloberflächenantigene
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
EA201690675A1
(ru)
|
2013-10-03 |
2016-08-31 |
Модерна Терапьютикс, Инк. |
Полинуклеотиды, кодирующие рецептор липопротеинов низкой плотности
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
US10288608B2
(en)
|
2013-11-08 |
2019-05-14 |
Prognosys Biosciences, Inc. |
Polynucleotide conjugates and methods for analyte detection
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
RU2714902C2
(ru)
|
2013-12-19 |
2020-02-20 |
Новартис Аг |
Химерные рецепторы антигена против мезотелина человека и их применение
|
GB201322692D0
(en)
|
2013-12-20 |
2014-02-05 |
Philochem Ag |
Production of encoded chemical libraries
|
US11193176B2
(en)
|
2013-12-31 |
2021-12-07 |
Bio-Rad Laboratories, Inc. |
Method for detecting and quantifying latent retroviral RNA species
|
WO2015120058A2
(en)
|
2014-02-05 |
2015-08-13 |
Molecular Templates, Inc. |
Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity
|
EP3647322B1
(de)
|
2014-03-20 |
2021-10-20 |
Bristol-Myers Squibb Company |
Stabilisierte fibronectinbasierte gerüstmoleküle
|
KR102472862B1
(ko)
|
2014-03-20 |
2022-12-05 |
브리스톨-마이어스 스큅 컴퍼니 |
혈청 알부민-결합 피브로넥틴 유형 iii 도메인
|
US10106579B2
(en)
|
2014-06-12 |
2018-10-23 |
Ra Pharmaceuticals, Inc. |
Modulation of complement activity
|
CN114057857A
(zh)
|
2014-06-20 |
2022-02-18 |
豪夫迈·罗氏有限公司 |
基于chagasin的支架组合物、方法和应用
|
WO2016011226A1
(en)
|
2014-07-16 |
2016-01-21 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
US9777061B2
(en)
|
2014-07-21 |
2017-10-03 |
Novartis Ag |
Treatment of cancer using a CD33 chimeric antigen receptor
|
JP6919118B2
(ja)
|
2014-08-14 |
2021-08-18 |
ノバルティス アーゲー |
GFRα−4キメラ抗原受容体を用いる癌の治療
|
BR112017003104A2
(pt)
|
2014-08-19 |
2017-12-05 |
Novartis Ag |
tratamento de câncer usando um receptor antigênico quimérico anti-cd123
|
MA40773A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus influenza a
|
MA40772A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus de la grippe a
|
BR112017010414A2
(pt)
|
2014-11-25 |
2018-05-15 |
Bristol-Myers Squibb Company |
métodos e composições para radiomarcação com 18f de substâncias biológicas
|
JP6622814B2
(ja)
|
2014-11-25 |
2019-12-18 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
イメージングのための新規pd−l1結合ポリペプチド
|
WO2016094881A2
(en)
|
2014-12-11 |
2016-06-16 |
Abbvie Inc. |
Lrp-8 binding proteins
|
EP3250230B9
(de)
|
2015-01-28 |
2022-02-23 |
RA Pharmaceuticals, Inc. |
Modulatoren der komplementaktivität
|
EP3061826A1
(de)
|
2015-02-27 |
2016-08-31 |
Novartis AG |
Flavivirus-replikons
|
EP4166664A1
(de)
|
2015-03-13 |
2023-04-19 |
Chugai Seiyaku Kabushiki Kaisha |
Modifizierte aminoacyl-trna-synthetase und verwendung davon
|
US10774374B2
(en)
|
2015-04-10 |
2020-09-15 |
Spatial Transcriptomics AB and Illumina, Inc. |
Spatially distinguished, multiplex nucleic acid analysis of biological specimens
|
US10787500B2
(en)
|
2015-04-10 |
2020-09-29 |
Adimab, Llc |
Methods for purifying heterodimeric multispecific antibodies from parental homodimeric antibody species
|
CN104774801A
(zh)
*
|
2015-04-14 |
2015-07-15 |
云南农业大学 |
一种核酸核糖体结合体系构建方法及应用
|
CN116063543A
(zh)
|
2015-04-24 |
2023-05-05 |
豪夫迈·罗氏有限公司 |
多特异性抗原结合蛋白
|
EP3985020A1
(de)
|
2015-04-24 |
2022-04-20 |
ViiV Healthcare UK (No.5) Limited |
Polypeptide zum targeting der hiv-fusion
|
PE20180193A1
(es)
|
2015-05-29 |
2018-01-26 |
Abbvie Inc |
Anticuerpos anti-cd40 y sus usos
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗vegf、pdgf及/或其受體之結合蛋白
|
US20190008887A1
(en)
*
|
2015-07-30 |
2019-01-10 |
ModernaTX Inc. |
Multimeric mrna
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
JP6893504B2
(ja)
|
2015-09-23 |
2021-06-23 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
速い解離速度を有する血清アルブミン結合フィブロネクチンタイプiiiドメイン
|
ES2809125T3
(es)
|
2015-09-23 |
2021-03-03 |
Bristol Myers Squibb Co |
Moléculas de armazón a base de fibronectina de unión a glipicano-3
|
DK3389692T3
(da)
|
2015-12-16 |
2020-03-30 |
Ra Pharmaceuticals Inc |
Modulatorer af komplement-aktivitet
|
WO2017165742A1
(en)
|
2016-03-24 |
2017-09-28 |
Millennium Pharmaceuticals, Inc. |
Methods of treating gastrointestinal immune-related adverse events in anti-ctla4 anti-pd-1 combination treatments
|
WO2017165778A1
(en)
|
2016-03-24 |
2017-09-28 |
Millennium Pharmaceuticals, Inc. |
Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments
|
WO2017210335A1
(en)
|
2016-06-01 |
2017-12-07 |
Bristol-Myers Squibb Company |
Imaging methods using 18f-radiolabeled biologics
|
US11344639B2
(en)
|
2016-06-01 |
2022-05-31 |
Bristol-Myers Squibb Company |
PET imaging with PD-L1 binding polypeptides
|
WO2018005559A1
(en)
|
2016-06-27 |
2018-01-04 |
Juno Therapeutics, Inc. |
Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
CN110461315A
(zh)
|
2016-07-15 |
2019-11-15 |
诺华股份有限公司 |
使用与激酶抑制剂组合的嵌合抗原受体治疗和预防细胞因子释放综合征
|
MX2019003473A
(es)
|
2016-10-03 |
2019-10-15 |
Abbott Lab |
Metodos mejorados para evaluar el estado de ubiquitin carboxi-terminal hidrolasa l1 (uch-l1) en muestras de pacientes.
|
US10525083B2
(en)
|
2016-10-07 |
2020-01-07 |
Novartis Ag |
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain
|
MX2019006527A
(es)
|
2016-12-07 |
2019-08-01 |
Ra Pharmaceuticals Inc |
Moduladores de la actividad del complemento.
|
US11382983B2
(en)
|
2017-01-13 |
2022-07-12 |
Academia Sinica |
Reloadable hydrogel system for treating brain conditions
|
WO2018130660A1
(en)
|
2017-01-13 |
2018-07-19 |
Academia Sinica |
Reloadable hydrogel system for treating myocardial infarction
|
US11286481B2
(en)
|
2017-03-17 |
2022-03-29 |
Cubicstars, Inc. |
Method for producing complex of RNA molecule and peptide, and utilization thereof
|
CA3052513A1
(en)
|
2017-03-23 |
2018-09-27 |
Abbott Laboratories |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
|
JP7344797B2
(ja)
|
2017-04-15 |
2023-09-14 |
アボット・ラボラトリーズ |
早期バイオマーカーを使用する、ヒト対象における外傷性脳損傷の、超急性の診断及び決定の一助となるための方法
|
CN110603449A
(zh)
|
2017-04-28 |
2019-12-20 |
雅培实验室 |
用同一人受试者的至少两种样品的早期生物标记物帮助超急性诊断确定创伤性脑损伤的方法
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
CN110651190A
(zh)
|
2017-05-25 |
2020-01-03 |
雅培实验室 |
用早期生物标记物帮助确定是否对已遭受或可能已遭受头部损伤的人受试者执行成像的方法
|
AU2018275235A1
(en)
|
2017-05-30 |
2019-10-31 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I and early biomarkers
|
EP3933408A1
(de)
|
2017-05-30 |
2022-01-05 |
Nant Holdings IP LLC |
Zirkulierende tumorzellenanreicherung unter verwendung von neoepitopen
|
WO2018225851A1
(ja)
|
2017-06-09 |
2018-12-13 |
中外製薬株式会社 |
N-置換アミノ酸を含むペプチドの合成方法
|
EP3649474A1
(de)
|
2017-07-03 |
2020-05-13 |
Abbott Laboratories |
Verbesserte verfahren zur messung von ubiquitin-carboxy-terminalen hydrolase-l1-konzentrationen in blut
|
EP3692370A2
(de)
|
2017-10-04 |
2020-08-12 |
OPKO Pharmaceuticals, LLC |
Artikel und verfahren zur personalisierten krebstherapie
|
AU2018358057B2
(en)
*
|
2017-10-31 |
2023-03-02 |
Encodia, Inc. |
Kits for analysis using nucleic acid encoding and/or label
|
WO2019112860A1
(en)
|
2017-12-09 |
2019-06-13 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of gfap and uch-l1
|
WO2019113525A2
(en)
|
2017-12-09 |
2019-06-13 |
Abbott Laboratories |
Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1)
|
US11492369B2
(en)
|
2017-12-15 |
2022-11-08 |
Chugai Seiyaku Kabushiki Kaisha |
Method for producing peptide, and method for processing bases
|
WO2019123262A1
(en)
|
2017-12-18 |
2019-06-27 |
VIIV Healthcare UK (No.5) Limited |
Antigen binding polypeptides
|
WO2019177690A1
(en)
|
2018-03-12 |
2019-09-19 |
Zoetis Services Llc |
Anti-ngf antibodies and methods thereof
|
EP3775261A4
(de)
|
2018-03-26 |
2021-11-24 |
Rootpath Genomics, Inc. |
Zusammensetzungen zielbindender einheiten und verwendungsverfahren
|
JPWO2020111238A1
(ja)
|
2018-11-30 |
2021-10-21 |
中外製薬株式会社 |
ペプチド化合物、またはアミド化合物の脱保護法および固相反応における脱樹脂方法、並びにペプチド化合物の製造方法
|
US11472885B2
(en)
*
|
2019-02-15 |
2022-10-18 |
Atreca, Inc. |
Antibodies that bind tumor tissue for diagnosis and therapy
|
WO2020198731A2
(en)
|
2019-03-28 |
2020-10-01 |
Danisco Us Inc |
Engineered antibodies
|
WO2020227554A1
(en)
|
2019-05-09 |
2020-11-12 |
Genentech, Inc. |
Methods of making antibodies
|
KR20220044534A
(ko)
|
2019-08-13 |
2022-04-08 |
엘피스 바이오파마슈티컬즈 |
조작된 인터류킨-2 수용체 베타 효능제
|
EP4055185A1
(de)
|
2019-11-08 |
2022-09-14 |
10X Genomics, Inc. |
Räumlich markierte analytfänger für analyt-multiplexing
|
IL295387A
(en)
|
2020-02-05 |
2022-10-01 |
Larimar Therapeutics Inc |
Peptide-binding proteins and their uses
|
JP2023515633A
(ja)
|
2020-02-28 |
2023-04-13 |
ブリストル-マイヤーズ スクイブ カンパニー |
放射性標識されたフィブロネクチンに基づく足場および抗体ならびにそのセラノスティクス的使用
|
CA3175523A1
(en)
|
2020-04-13 |
2021-10-21 |
Antti Virtanen |
Methods, complexes and kits for detecting or determining an amount of a .beta.-coronavirus antibody in a sample
|
EP4188949A1
(de)
|
2020-07-31 |
2023-06-07 |
NantBio, Inc. |
Chimäre t-zell-rezeptoren, nukleinsäuren und verfahren zur herstellung und verwendung davon
|
EP4193149A1
(de)
|
2020-08-04 |
2023-06-14 |
Abbott Laboratories |
Verbesserte verfahren und kits zum nachweis von sars-cov-2-protein in einer probe
|
WO2022104001A1
(en)
|
2020-11-13 |
2022-05-19 |
Bristol-Myers Squibb Company |
Expanded protein libraries and uses thereof
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
US20220170948A1
(en)
|
2020-12-01 |
2022-06-02 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a human subject having received a head computerized tomography scan that is negative for a tbi
|
WO2022140028A1
(en)
|
2020-12-21 |
2022-06-30 |
10X Genomics, Inc. |
Methods, compositions, and systems for capturing probes and/or barcodes
|
EP4271998A1
(de)
|
2020-12-30 |
2023-11-08 |
Abbott Laboratories |
Verfahren zur bestimmung des sars-cov-2-antigens und anti-sars-cov-2-antikörpers in einer probe
|
CN117083297A
(zh)
|
2021-01-22 |
2023-11-17 |
艾佩斯瑞生物制药公司 |
抗PD-L1单克隆抗体以及与白细胞介素-15(IL-15)、白细胞介素-15受体15α或白细胞介素-2的融合蛋白
|
US11792839B2
(en)
|
2021-03-12 |
2023-10-17 |
Eagle Technology, Llc |
Systems and methods for controlling communications based on machine learned information
|
EP4301870A1
(de)
|
2021-03-18 |
2024-01-10 |
10X Genomics, Inc. |
Multiplex-erfassung von gen- und proteinexpression aus einer biologischen probe
|
CA3216320A1
(en)
|
2021-05-18 |
2022-11-24 |
Abbott Laboratories |
Methods of evaluating brain injury in a pediatric subject
|
WO2022266034A1
(en)
|
2021-06-14 |
2022-12-22 |
Abbott Laboratories |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
CA3230038A1
(en)
|
2021-08-31 |
2023-03-09 |
Hongwei Zhang |
Methods and systems of diagnosing brain injury
|
AU2022354059A1
(en)
|
2021-09-30 |
2024-03-28 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
WO2023114978A1
(en)
|
2021-12-17 |
2023-06-22 |
Abbott Laboratories |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
US20230213536A1
(en)
|
2021-12-28 |
2023-07-06 |
Abbott Laboratories |
Use of biomarkers to determine sub-acute traumatic brain injury (tbi) in a subject having received a head computerized tomography (ct) scan that is negative for a tbi or no head ct scan
|
WO2023150652A1
(en)
|
2022-02-04 |
2023-08-10 |
Abbott Laboratories |
Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
|
WO2023220597A1
(en)
|
2022-05-10 |
2023-11-16 |
Elpis Biopharmaceuticals |
Engineered interleukin-2 receptor beta reduced-binding agonist
|
WO2024006876A1
(en)
|
2022-06-29 |
2024-01-04 |
Abbott Laboratories |
Magnetic point-of-care systems and assays for determining gfap in biological samples
|
WO2024059708A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Biomarkers and methods for differentiating between mild and supermild traumatic brain injury
|